While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.

The investment quickly bore fruit: The FDA approved a record-breaking number of generic drugs in 2017 and 2018, yielding an estimated $26 billion in savings for American consumers.

In 2015, only 19 percent of generic drugs covered by Medicare were in the preferred formulary tiers with the lowest out-of-pocket costs, found a study last year by consultants Avalere.

Generic drugs, whether they’re antibiotics, diabetes drugs or statins to lower cholesterol, sell for “pennies per dose,” said Tom Kraus, vice president of government relations for the ...

Some 40% of generic drugs have only one or two companies making their ingredients, so it’s a “pretty fragile supply,” Rena Conti, an associate professor at the Boston University Questrom ...

More than 90% of U.S. prescriptions are for generic drugs, yet more than 80% of the raw materials crucial for drug production are sourced overseas, led by India and China.

Health Top 10 most expensive prescription drugs in the US by price and by sales volume Following Trump’s price-slashing executive order, a spotlight on which drugs could be affected ...

If pharmaceutical tariffs cause an increase in any drug prices, Democrats could jump on the issue for the midterm elections next year and try to undercut Mr. Trump’s popularity among working ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects ...

But a similar drug, elacestrant, made by Stemline Therapeutics, typically costs $26,467.56 a month. (It and other estrogen receptor degraders, though, have not been tested in this setting, before ...

Generic drugs, whether they’re antibiotics, diabetes drugs or statins to lower cholesterol, sell for “pennies per dose,” said Tom Kraus, vice president of government relations for the ...